• Community News
  • Medical and Scientific News
  • Features
Canadian Hemophilia Society
  • Français
chsLogo
  • Community News
  • Medical and Scientific News
  • Features
Home / Articles posted by David Page (Page 4)
  • Approvals of Hemlibra – The devil is in the details

    By David Page on September 13, 2021

    Montreal, September 13, 2021 – In recent weeks, governments in both Quebec and the rest of Canada have expanded access to Hemlibra to patients with...

  • Hemlibra approved by provinces/territories

    By David Page on September 9, 2021

    September 9, 2021, Montréal – The Canadian Hemophilia Society (CHS) was informed late yesterday by Canadian Blood Services (CBS) that access to Hemlibra (emicizumab) will...

  • Québec approves Hemlibra but …

    By David Page on August 20, 2021

    August 20, 2021, Montréal – The Canadian Hemophilia Society – Quebec Chapter (CHSQ) has learned that the Québec Ministère de la Santé et des Services...

  • Still no word on access to Hemlibra two years after Health Canada’s approval

    By David Page on August 8, 2021

    August 8, 2021, Montreal – There is still no word on access to Hemlibra from ministries of health in Quebec and the rest of Canada...

  • UPDATE – Supply of DDAVP injectable discontinued

    By David Page on June 23, 2021

    Ferring says supply of DDAVP injectable to return in “one to two months” Montreal, June 23, 2021 – Ferring Canada, in discussions with the Canadian...

Page 4 of 9123456789
  • KEYWORDS

    ADVOCACY ageing A GLOBAL PERSPECTIVE AIDS CARRIERS COMPENSATION COVID-19 EMICIZUMAB GENE THERAPY HALF-LIFE FACTOR CONCENTRATES HEMLIBRA HEMOPHILIA A AND B HEPATITIS C HIV ICHIP INHIBITORS MYCBDR NURSING PHYSIOTHERAPY Platelet function disorders PROBE PROPHYLAXIS RARE BLEEDING DISORDERS RESEARCH SOCIAL WORK THE BLOOD FACTOR THE FEMALE FACTOR THERAPIES THE SAGE PAGE TWINNING VON WILLEBRAND DISEASE

Copyright © 2020 - Canadian Hemophilia Society. All rights reserved.

  • ARCHIVED HEMOPHILIA TODAY
  • ABOUT US